Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-Current Debt (2019 - 2025)

Biodesix's Non-Current Debt history spans 7 years, with the latest figure at $47.4 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 30.31% year-over-year to $47.4 million; the TTM value through Dec 2025 reached $47.4 million, up 30.31%, while the annual FY2025 figure was $47.4 million, 30.31% up from the prior year.
  • Non-Current Debt reached $47.4 million in Q4 2025 per BDSX's latest filing, up from $47.1 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $47.4 million in Q4 2025 to a low of $4.9 million in Q3 2022.
  • Average Non-Current Debt over 5 years is $29.0 million, with a median of $30.2 million recorded in 2021.
  • Peak YoY movement for Non-Current Debt: tumbled 83.72% in 2022, then surged 411.27% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $10.0 million in 2021, then soared by 150.22% to $25.0 million in 2022, then soared by 40.88% to $35.2 million in 2023, then grew by 3.36% to $36.4 million in 2024, then surged by 30.31% to $47.4 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Non-Current Debt are $47.4 million (Q4 2025), $47.1 million (Q3 2025), and $46.8 million (Q2 2025).